NUTRIENTS AS NOVEL THERAPEUTIC APPROACHES FOR METABOLIC DISTURBANCES IN POLYCYSTIC OVARY SYNDROME

被引：12

作者：

Mansour, Asieh ^{[1
,2
]}

Hosseini, Saeed ^{[2
]}

Larijani, Bagher ^{[2
]}

Mohajeri-Tehrani, Mohammad Reza ^{[2
]}

机构：

[1] Shahid Beheshti Univ Med Sci, Res Inst, Dept Clin Nutr & Dietet, Fac Nutr & Food Technol,Natl Nutr & Food Technol, Tehran, Iran

[2] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran

来源：

EXCLI JOURNAL | 2016年 / 15卷

关键词：

Polycystic ovary syndrome; inositol; isoflavonids; resveratrol; vitamin D; PUFA; D-CHIRO-INOSITOL; RANDOMIZED CLINICAL-TRIAL; VITAMIN-D SUPPLEMENTATION; THECA-INTERSTITIAL CELLS; OXIDATIVE STRESS; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; OVERWEIGHT PATIENTS; D DEFICIENCY; OBESE WOMEN;

D O I：

10.17179/excli2016-422

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women. This disease is characterized by infertility, menstrual dysfunction, and hyperandrogenism. Also, PCOS is often associated with hyperlipidemia and impaired glucose tolerance, conditions that are associated with cardiovascular disorder, type 2 diabetes, cancer and hypertension. Evidence supports that some nutrients may affect the hormonal and metabolic disturbances of PCOS. Here in this study, we aimed to review the available literature that assessed the nutrients such as inostol, isoflavonids, resveratrol, vitamin D, and PUFA (polyunsaturated fatty acids), known to influence the hormonal and metabolic disturbances of PCOS, along with the strategies and future directions of nutrient supplementations in such patients.

引用

页码：551 / 564

页数：14

共 50 条

[21] Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome
Cussons, Andrea J.
Watts, Gerald F.
Burke, Valerie
Shaw, Jonathan E.
Zimmet, Paul Z.
Stuckey, Bronwyn G. A.
HUMAN REPRODUCTION, 2008, 23 (10) : 2352 - 2358
[22] THE PHARMACOGENETIC APPROACHES IN POLYCYSTIC OVARY SYNDROME
Karadeniz, Muammer
Bozok-Cetintas, Vildan
Tetik, Asli
Zengi, Ayhan
Erdogan, Mehmet
Cetinkalp, Sevki
Eroglu, Zuhal
Yilmaz, Candeger
IUBMB LIFE, 2009, 61 (03) : 387 - 387
[23] Is there a polycystic ovary syndrome without metabolic syndrome?
Janssen, O. E.
Hahn, S.
DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (02) : 95 - 96
[24] Metabolic syndrome in patients with the polycystic ovary syndrome
Panidis, Dimitrios
Tziomalos, Konstantinos
Papadakis, Efstathios
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (06) : 559 - 568
[25] Polycystic ovary syndrome: A component of metabolic syndrome?
Vignesh, J. P.
Mohan, V
JOURNAL OF POSTGRADUATE MEDICINE, 2007, 53 (02) : 128 - 134
[26] Metabolic syndrome in adolescents with polycystic ovary syndrome
Vrbikova, Jana
Zamrazilova, Hana
Sedlackova, Barbora
Sanajderova, Marta
GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (10) : 820 - 822
[27] Dietary approaches for polycystic ovary syndrome
Farhat, Antoine G.
Mansour, Marisa B.
Attieh, Remi W.
NUTRITION & FOOD SCIENCE, 2011, 41 (05): : 326 - 343
[28] Metabolic syndrome in women with polycystic ovary syndrome
Essah, Paulina A.
Nestler, John E.
FERTILITY AND STERILITY, 2006, 86 : S18 - S19
[29] Metabolic syndrome in women with polycystic ovary syndrome
Chandrasekaran, Swaramya
Sagili, Haritha
OBSTETRICIAN & GYNAECOLOGIST, 2018, 20 (04): : 245 - 252
[30] The metabolic effects of polycystic ovary syndrome
Bednarek-Tupikowska, Grazyna
Bucyk, Barbara
FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2008, 10 (03): : 769 - 774

← 1 2 3 4 5 →